The last decade has seen significant advances in our understanding of lung cancer biology
and management. Identification of key driver events in lung carcinogenesis has contributed …

Context—Traditionally, lung cancer has been viewed as an aggressive, relentlessly
progressive disease with few treatment options and poor survival. The traditional role of the …

Lung cancer can be diagnosed pathologically based either on histologic biopsy or cytologic
specimens. 1, 2 In the 2015 World Health Organization (WHO) Classification of Lung Tumors …

The discoveries of cancer research have been translated into the clinical management of
lung cancer patients. So far, the approach of targeted therapy that is directed towards certain …

While histopathology has traditionally been the cornerstone of treatment decisions in the
management of lung cancer patients, the complexity and heterogeneity of histological …

Lung cancer is the leading cause of cancer-related death worldwide with a 5-year survival
rate of less than 15%, despite significant advances in both diagnostic and therapeutic …

We summarize significant changes in pathologic classification of lung cancer resulting from
the 2011 International Association for the Study of Lung Cancer/American Thoracic …

Significant progress has been made in the understanding of lung cancer biology, due in
large part to advancement in the understanding of tumor biology and pathogenesis …

Worldwide, lung cancer is the most common cause of major cancer incidence and mortality
in men, whereas in women it is the third most common cause of cancer incidence and the …

Abstract The new the International Association for the Study of Lung Cancer (IASLC)/the
American Thoracic Society (ATS)/the European Respiratory Society (ERS) pathologic …